Klic receives a favorable analyst opinion
-------------------------
MINNEAPOLIS, Mar 19, 2001 (BUSINESS WIRE) -- BlueFire Research, an SEC registered investment adviser affiliated with BlueFire Partners, today announced a new investment opinion on Hypertension Diagnostics Inc. (Nasdaq:HDII- $4 5/16). BlueFire Research has given Hypertension Diagnostics an OUTPERFORM rating for speculative investors and a 12-month target price of $8 7/8 per share. Hypertension Diagnostics is at the launch phase of an FDA-approved screening and diagnostic system for human arterial elasticity, a key indicator for many forms of cardiovascular disease.
"We are initiating coverage of Hypertension Diagnostics common stock with an OUTPERFORM rating for speculative investors," said Joanne B. Henry, Managing Director of BlueFire Research, Inc. "Hypertension Diagnostics has persevered in the development of breakthrough technology for the analysis of arterial health, and today the company is selling these systems for academic and research applications. The real opportunity for investors, however, lies with the per-test fees for usage among general practice doctors, cardiologists, internists, and other physicians to screen their patients for cardiovascular health. The company will be launching this product shortly, and within months we expect the company to be producing revenue as systems are placed in clinics in the company's 25 target markets.
"We believe revenue can grow to more than $18 million in the year ended June 2003, " Henry said. "With that kind of growth potential, we believe that the stock could appreciate significantly from its current price."
The initial research report on Hypertension Diagnostics will be made available to BlueFire's proprietary database of investment professionals and through nationally recognized services that currently provide equity research online or by traditional subscription means. For more information and a copy of the Hypertension Diagnostics report, please send an electronic mail message to tbart@bluefirepartners.com or telephone (612) 344-1032. Bluefire Research reports are also available online at www.bluefirepartners.com/bfr/index.shtml.
BlueFire Research was formed in January 2000 by Minneapolis-based BlueFire Partners to provide investment research on small capitalization growth companies in health care, technology, telecommunications, financial institutions, consumer, and industrial growth sectors. BlueFire Research prepares and provides research reports and periodic updates to investment professionals and the investment community on mid-cap, small-cap and micro-cap companies who, in most cases, are clients of BlueFire Partners.
About BlueFire Partners
BlueFire Partners is an independent, privately held professional firm providing strategic consulting services focused on enhancing the enterprise value of its clients. With headquarters in Minneapolis, BlueFire has a national reputation for expertise in advising growing companies in the areas of corporate strategy, investor relations, public relations, graphic design services, media relations, product launch campaigns, performance improvement initiatives and leadership development. BlueFire Research, a subsidiary of BlueFire Capital Markets Group, is an SEC-registered investment adviser providing investment research on small-capitalization growth companies and other investment advisory services. Bluefire Research reports and updates are available online at www.bluefirepartners.com/bfr/index.shtml.
The research report on Hypertension Diagnostics was prepared by BlueFire Research, a Registered Investment Adviser, and an affiliate of a company that provides a variety of professional services for the subject company of this report. However, the subject company of this report has paid no direct compensation to the investment adviser or its affiliate for the preparation, distribution, and dissemination of this report. This report is for information purposes only and does not constitute an offer or solicitation of an offer to buy or sell any securities. The information provided, while not guaranteed as to accuracy or completeness, has been obtained from sources believed to be reliable. No officer, director or employee of BlueFire Research, or its affiliates, owns securities in the subject company of this report unless it is specifically disclosed.
CONTACT: BlueFire Research, Minneapolis
Lee Schafer or Joanne Henry, 612/344-1011
Copyright (C) 2001 Business Wire. All rights reserved.
-------------------------- |
